CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-05 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise · Restricted Stock Units | −8,060 | 0 | ||
| 2023-07-21 | Kummeth Charles R. Chief Executive Officer | Sale 10b5-1 | −80,000 | $88.36 | $7.1M | 1,258,766 |
| 2023-06-30 | Kummeth Charles R. Chief Executive Officer | Option exercise | +616,676 | $26.65 | $16.4M | 1,729,493 |
| 2023-06-30 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −390,727 | $81.63 | $31.9M | 1,338,766 |
| 2023-06-30 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −616,676 | 0 | ||
| 2023-06-07 | Kummeth Charles R. Chief Executive Officer | Sale | −322 | $83.00 | $27K | 1,112,817 |
| 2023-04-28 | HIGGINS JOHN L Director | Option exercise | +16,000 | $21.85 | $350K | 39,360 |
| 2023-04-28 | HIGGINS JOHN L Director | Shares withheld for taxes | −4,377 | $79.88 | $350K | 34,983 |
| 2023-04-28 | HIGGINS JOHN L Director | Option exercise · Stock Options (Right to Buy) | −16,000 | 0 | ||
| 2023-04-19 | Nusse Roeland Director | Gift | −377 | 28,811 | ||
| 2023-04-03 | Bohnen Shane SVP - General Counsel | Grant or award · Restricted Stock Units | +6,778 | 6,778 | ||
| 2023-04-03 | Bohnen Shane SVP - General Counsel | Grant or award · Stock Option (right to buy) | +3,928 | 3,928 | ||
| 2023-01-04 | Kummeth Charles R. Chief Executive Officer | Option exercise | +407,364 | $26.65 | $10.9M | 1,368,976 |
| 2023-01-04 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −255,837 | $84.39 | $21.6M | 1,113,139 |
| 2023-01-04 | Kummeth Charles R. Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −407,364 | 616,676 | ||
| 2022-12-08 | Furlow Brenda S. SVP - GENERAL COUNSEL | Option exercise | +7,450 | $31.26 | $233K | 33,542 |
| 2022-12-08 | Furlow Brenda S. SVP - GENERAL COUNSEL | Sale | −7,450 | $82.12 | $612K | 26,092 |
| 2022-12-08 | Furlow Brenda S. SVP - GENERAL COUNSEL | Option exercise · Stock Options (Right to Buy) | −7,450 | 29,762 | ||
| 2022-12-07 | Furlow Brenda S. SVP - GENERAL COUNSEL | Option exercise | +800 | $31.26 | $25K | 26,892 |
| 2022-12-07 | Furlow Brenda S. SVP - GENERAL COUNSEL | Sale | −800 | $82.01 | $66K | 26,092 |
Page 21 of 32 · 626 trades